메뉴 건너뛰기




Volumn 14, Issue 14, 2013, Pages 1793-1803

Renal cell carcinoma development and miRNAs: A possible link to the EGFR pathway

Author keywords

Biomarkers; EGFR; MiRNAs; Renal cell carcinoma; Targeted therapies; VHL

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 1233; MICRORNA 155; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 222; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

EID: 84897086609     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.184     Document Type: Review
Times cited : (30)

References (70)
  • 1
    • 80052270947 scopus 로고    scopus 로고
    • The epidemiology of renal cell carcinoma
    • Ljungberg B, Campbell SC, Choi HY et al. The epidemiology of renal cell carcinoma. Eur. Urol. 60(4), 615-621 (2011).
    • (2011) Eur. Urol. , vol.60 , Issue.4 , pp. 615-621
    • Ljungberg, B.1    Campbell, S.C.2    Choi, H.Y.3
  • 2
    • 77955493600 scopus 로고    scopus 로고
    • EAU guidelines on renal cell carcinoma: The 2010 update
    • Ljungberg B, Cowan NC, Hanbury DC et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur. Urol. 58(3), 398-406 (2010).
    • (2010) Eur. Urol. , vol.58 , Issue.3 , pp. 398-406
    • Ljungberg, B.1    Cowan, N.C.2    Hanbury, D.C.3
  • 3
    • 78049484272 scopus 로고    scopus 로고
    • Integrating surgery with targeted therapies for renal cell carcinoma: Current evidence and ongoing trials
    • Bex A, Jonasch E, Kirkali Z et al. Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials. Eur. Urol. 58(6), 819-828 (2010).
    • (2010) Eur. Urol. , vol.58 , Issue.6 , pp. 819-828
    • Bex, A.1    Jonasch, E.2    Kirkali, Z.3
  • 5
    • 77952545672 scopus 로고    scopus 로고
    • TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe
    • Szymanska K, Moore LE, Rothman N et al. TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe. Cancer Lett. 293(1), 92-98 (2010).
    • (2010) Cancer Lett. , vol.293 , Issue.1 , pp. 92-98
    • Szymanska, K.1    Moore, L.E.2    Rothman, N.3
  • 6
    • 80052263465 scopus 로고    scopus 로고
    • ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of metastatic disease
    • Patard JJ, Pignot G, Escudier B et al. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease. Eur. Urol. 60(4), 684-690 (2011).
    • (2011) Eur. Urol. , vol.60 , Issue.4 , pp. 684-690
    • Patard, J.J.1    Pignot, G.2    Escudier, B.3
  • 8
    • 79651472671 scopus 로고    scopus 로고
    • MicroRNAs and their target gene networks in renal cell carcinoma
    • Redova M, Svoboda M, Slaby O. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem. Biophys. Res. Commun. 405(2), 153-156 (2011).
    • (2011) Biochem. Biophys. Res. Commun. , vol.405 , Issue.2 , pp. 153-156
    • Redova, M.1    Svoboda, M.2    Slaby, O.3
  • 10
    • 4644363095 scopus 로고    scopus 로고
    • The von Hippel-Lindau tumor suppressor gene and kidney cancer
    • Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin. Cancer Res. 10(18 Pt 2), 6290S-6295S (2004).
    • (2004) Clin. Cancer Res. , vol.10 , Issue.18 PART 2
    • Kaelin Jr., W.G.1
  • 11
    • 0035835819 scopus 로고    scopus 로고
    • The von Hippel-Lindau tumor suppressor gene
    • Kondo K, Kaelin WG Jr. The von Hippel-Lindau tumor suppressor gene. Exp. Cell. Res. 264(1), 117-125 (2001).
    • (2001) Exp. Cell. Res. , vol.264 , Issue.1 , pp. 117-125
    • Kondo, K.1    Kaelin Jr., W.G.2
  • 12
    • 0037326037 scopus 로고    scopus 로고
    • The von Hippel-Lindau tumor suppressor hypoxia-inducible factor-1 (HIF-1) degradation and cancer pathogenesis
    • Pugh CW, Ratcliffe PJ. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13(1), 83-89 (2003).
    • (2003) Semin. Cancer Biol. , vol.13 , Issue.1 , pp. 83-89
    • Pugh, C.W.1    Ratcliffe, P.J.2
  • 13
    • 50849090006 scopus 로고    scopus 로고
    • Von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1
    • Lee SJ, Lattouf JB, Xanthopoulos J, Linehan WM, Bottaro DP, Vasselli JR. von Hippel-Lindau tumor suppressor gene loss in renal cell carcinoma promotes oncogenic epidermal growth factor receptor signaling via Akt-1 and MEK-1. Eur. Urol. 54(4), 845-853 (2008).
    • (2008) Eur. Urol. , vol.54 , Issue.4 , pp. 845-853
    • Lee, S.J.1    Lattouf, J.B.2    Xanthopoulos, J.3    Linehan, W.M.4    Bottaro, D.P.5    Vasselli, J.R.6
  • 15
    • 65349117540 scopus 로고    scopus 로고
    • Clinical implications of hypoxia inducible factor in renal cell carcinoma
    • Smaldone MC, Maranchie JK. Clinical implications of hypoxia inducible factor in renal cell carcinoma. Urol. Oncol. 27(3), 238-245 (2009).
    • (2009) Urol. Oncol. , vol.27 , Issue.3 , pp. 238-245
    • Smaldone, M.C.1    Maranchie, J.K.2
  • 16
    • 46749122616 scopus 로고    scopus 로고
    • Prognostic factors for renall cell carcinoma
    • Furniss D, Harden P, Ali N et al. Prognostic factors for renall cell carcinoma. Cancer Treat. Rev. 34, 407-426 (2008).
    • (2008) Cancer Treat. Rev. , vol.34 , pp. 407-426
    • Furniss, D.1    Harden, P.2    Ali, N.3
  • 17
    • 20444485232 scopus 로고    scopus 로고
    • Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2 driven VHL-/-renal cancer
    • Smith K, Gunaratnam L, Morley M. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2 driven VHL-/-renal cancer. Cancer Res. 65(12), 5221-5230 (2005).
    • (2005) Cancer Res. , vol.65 , Issue.12 , pp. 5221-5230
    • Smith, K.1    Gunaratnam, L.2    Morley, M.3
  • 18
    • 74549114727 scopus 로고    scopus 로고
    • Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
    • Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 277, 301-308 (2009).
    • (2009) FEBS J. , vol.277 , pp. 301-308
    • Mitsudomi, T.1    Yatabe, Y.2
  • 20
    • 84891484340 scopus 로고    scopus 로고
    • Drug delivery and drug resistance: EGFR-tyrosine kinase inhibitors in non-small cell lung cancer
    • Olcay E, Giovannetti E, Peters G. Drug delivery and drug resistance: EGFR-tyrosine kinase inhibitors in non-small cell lung cancer. Open Lung Cancer J. 3, 26-33 (2010).
    • (2010) Open Lung Cancer J. , vol.3 , pp. 26-33
    • Olcay, E.1    Giovannetti, E.2    Peters, G.3
  • 21
    • 11244319884 scopus 로고    scopus 로고
    • A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter
    • Liu W, Innocenti F, Wu M et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 65(1), 46-53 (2005).
    • (2005) Cancer Res. , vol.65 , Issue.1 , pp. 46-53
    • Liu, W.1    Innocenti, F.2    Wu, M.3
  • 22
    • 1842471336 scopus 로고    scopus 로고
    • Signaling through the epidermal growth factor receptor during the development of malignancy
    • Grandis J, Sok J. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol. Ther. 102, 37-46 (2004).
    • (2004) Pharmacol. Ther. , vol.102 , pp. 37-46
    • Grandis, J.1    Sok, J.2
  • 23
    • 80052854931 scopus 로고    scopus 로고
    • The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR
    • Zhou L, Yang H. The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR. PLoS ONE 6(9), e23936 (2011).
    • (2011) PLoS ONE , vol.6 , Issue.9
    • Zhou, L.1    Yang, H.2
  • 24
    • 61949090107 scopus 로고    scopus 로고
    • Regulation of endocytosis via the oxygen-sensing pathway
    • Wang Y, Roche O, Yan MS et al. Regulation of endocytosis via the oxygen-sensing pathway. Nat. Med. 15(3), 319-324 (2009).
    • (2009) Nat. Med. , vol.15 , Issue.3 , pp. 319-324
    • Wang, Y.1    Roche, O.2    Yan, M.S.3
  • 25
    • 84878108145 scopus 로고    scopus 로고
    • EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
    • Shen J, Xia W, Khotskaya YB et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497(7449), 383-387 (2013).
    • (2013) Nature , vol.497 , Issue.7449 , pp. 383-387
    • Shen, J.1    Xia, W.2    Khotskaya, Y.B.3
  • 26
    • 45849094041 scopus 로고    scopus 로고
    • Update on the medical treatment of metastatic renal cell carcinoma
    • Ravaud A, Wallerand H, Culine S et al. Update on the medical treatment of metastatic renal cell carcinoma. Eur. Urol. 54(2), 315-325 (2008).
    • (2008) Eur. Urol. , vol.54 , Issue.2 , pp. 315-325
    • Ravaud, A.1    Wallerand, H.2    Culine, S.3
  • 27
    • 50649099256 scopus 로고    scopus 로고
    • Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma
    • Rini BI, Flaherty K. Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma. Urol. Oncol. 26(5), 543-549 (2008).
    • (2008) Urol. Oncol. , vol.26 , Issue.5 , pp. 543-549
    • Rini, B.I.1    Flaherty, K.2
  • 28
    • 84867143840 scopus 로고    scopus 로고
    • Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma
    • Ravaud A, Gross-Goupil M. Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma. Cancer Treat. Rev. 38(8), 996-1003 (2012).
    • (2012) Cancer Treat. Rev. , vol.38 , Issue.8 , pp. 996-1003
    • Ravaud, A.1    Gross-Goupil, M.2
  • 29
    • 80054691489 scopus 로고    scopus 로고
    • Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development
    • Gambari R, Fabbri E, Borgatti M et al. Targeting microRNAs involved in human diseases: a novel approach for modification of gene expression and drug development. Biochem. Pharmacol. 82(10), 1416-1429 (2011).
    • (2011) Biochem. Pharmacol. , vol.82 , Issue.10 , pp. 1416-1429
    • Gambari, R.1    Fabbri, E.2    Borgatti, M.3
  • 30
    • 84859652376 scopus 로고    scopus 로고
    • Secretory miRNAs as novel cancer biomarkers
    • Zhang J, Zhao H, Gao Y, Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochim. Biophys. Acta 1826(1), 32-43 (2012).
    • (2012) Biochim. Biophys. Acta , vol.1826 , Issue.1 , pp. 32-43
    • Zhang, J.1    Zhao, H.2    Gao, Y.3    Zhang, W.4
  • 31
    • 84869866890 scopus 로고    scopus 로고
    • MicroRNA and cancer
    • Jansson MD, Lund AH. MicroRNA and cancer. Mol. Oncol. 6(6), 590-610 (2012).
    • (2012) Mol. Oncol. , vol.6 , Issue.6 , pp. 590-610
    • Jansson, M.D.1    Lund, A.H.2
  • 32
    • 84869887497 scopus 로고    scopus 로고
    • DNA methylation and microRNA dysregulation in cancer
    • Suzuki H, Maruyama R, Yamamoto E, Kai M. DNA methylation and microRNA dysregulation in cancer. Mol. Oncol. 6(6), 567-578 (2012).
    • (2012) Mol. Oncol. , vol.6 , Issue.6 , pp. 567-578
    • Suzuki, H.1    Maruyama, R.2    Yamamoto, E.3    Kai, M.4
  • 35
    • 79953249325 scopus 로고    scopus 로고
    • MicroRNA in prostate, bladder, and kidney cancer: A systematic review
    • Catto JW, Alcaraz A, Bjartell AS et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 59(5), 671-681 (2011).
    • (2011) Eur. Urol. , vol.59 , Issue.5 , pp. 671-681
    • Catto, J.W.1    Alcaraz, A.2    Bjartell, A.S.3
  • 36
    • 72649084669 scopus 로고    scopus 로고
    • Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis
    • Chow TF, Youssef YM, Lianidou E et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. Clin. Biochem. 43(1-2), 150-158 (2010).
    • (2010) Clin. Biochem. , vol.43 , Issue.1-2 , pp. 150-158
    • Chow, T.F.1    Youssef, Y.M.2    Lianidou, E.3
  • 37
    • 84881163733 scopus 로고    scopus 로고
    • Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: A study in a southern European population
    • Marques I, Teixeira AL, Ferreira M et al. Influence of survivin (BIRC5) and caspase-9 (CASP9) functional polymorphisms in renal cell carcinoma development: a study in a southern European population. Mol. Biol. Rep. 40(8), 4819-4826 (2013).
    • (2013) Mol. Biol. Rep. , vol.40 , Issue.8 , pp. 4819-4826
    • Marques, I.1    Teixeira, A.L.2    Ferreira, M.3
  • 38
    • 77954386364 scopus 로고    scopus 로고
    • MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
    • Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42(8), 1273-1281 (2010).
    • (2010) Int. J. Biochem. Cell Biol. , vol.42 , Issue.8 , pp. 1273-1281
    • Cho, W.C.1
  • 39
    • 84871092992 scopus 로고    scopus 로고
    • The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared with the proximal tubular epithelial cells of the kidney
    • Duns G, van den Berg A, van Dijk MC et al. The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared with the proximal tubular epithelial cells of the kidney. Genes Chromosomes Cancer 52(2), 165-173 (2012).
    • (2012) Genes Chromosomes Cancer , vol.52 , Issue.2 , pp. 165-173
    • Duns, G.1    Van Den Berg, A.2    Van Dijk, M.C.3
  • 40
    • 84879890360 scopus 로고    scopus 로고
    • Comprehensive molecular characterization of clear cell renal cell carcinoma
    • Cancer Genome Atlas Research Network.
    • Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499(7456), 43-49 (2013).
    • (2013) Nature , vol.499 , Issue.7456 , pp. 43-49
  • 41
    • 84870654513 scopus 로고    scopus 로고
    • MiR-21 downregulated TCF21 to inhibit KISS1 in renal cancer
    • Zhang H, Guo Y, Shang C, Song Y, Wu B. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. Urology 80(6), 1298-1302 (2012).
    • (2012) Urology , vol.80 , Issue.6 , pp. 1298-1302
    • Zhang, H.1    Guo, Y.2    Shang, C.3    Song, Y.4    Wu, B.5
  • 42
    • 36649025655 scopus 로고    scopus 로고
    • OncomiRs: The discovery and progress of microRNAs in cancers
    • Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 6, 60 (2007).
    • (2007) Mol. Cancer , vol.6 , pp. 60
    • Cho, W.C.1
  • 43
    • 77956339881 scopus 로고    scopus 로고
    • OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
    • Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467(7311), 86-90 (2010).
    • (2010) Nature , vol.467 , Issue.7311 , pp. 86-90
    • Medina, P.P.1    Nolde, M.2    Slack, F.J.3
  • 44
    • 80053923978 scopus 로고    scopus 로고
    • Prognostic role of microRNA-21 in various carcinomas: A systematic review and meta-analysis
    • Fu X, Han Y, Wu Y et al. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur. J. Clin. Invest. 41(11), 1245-1253 (2011).
    • (2011) Eur. J. Clin. Invest. , vol.41 , Issue.11 , pp. 1245-1253
    • Fu, X.1    Han, Y.2    Wu, Y.3
  • 45
    • 78650385772 scopus 로고    scopus 로고
    • MicroRNA-21: A novel therapeutic target in human cancer
    • Pan X, Wang ZX, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol. Ther. 10(12), 1224-1232 (2010).
    • (2010) Cancer Biol. Ther. , vol.10 , Issue.12 , pp. 1224-1232
    • Pan, X.1    Wang, Z.X.2    Wang, R.3
  • 46
    • 79955534639 scopus 로고    scopus 로고
    • MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1a expression
    • Liu LZ, Li C, Chen Q et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1a expression. PLoS ONE 6(4), e19139 (2011).
    • (2011) PLoS ONE , vol.6 , Issue.4
    • Liu, L.Z.1    Li, C.2    Chen, Q.3
  • 47
    • 75949106927 scopus 로고    scopus 로고
    • Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
    • Zhou X, Ren Y, Moore L et al. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. Lab. Invest. 90(2), 144-155 (2010).
    • (2010) Lab. Invest. , vol.90 , Issue.2 , pp. 144-155
    • Zhou, X.1    Ren, Y.2    Moore, L.3
  • 48
    • 80053597754 scopus 로고    scopus 로고
    • MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia
    • Bruning U, Cerone L, Neufeld Z et al. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol. Cell. Biol. 31(19), 4087-4096 (2011).
    • (2011) Mol. Cell. Biol. , vol.31 , Issue.19 , pp. 4087-4096
    • Bruning, U.1    Cerone, L.2    Neufeld, Z.3
  • 49
    • 84877621093 scopus 로고    scopus 로고
    • MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma
    • Shinmei S, Sakamoto N, Goto K et al. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int. J. Urol. 20(5), 468-477 (2013).
    • (2013) Int. J. Urol. , vol.20 , Issue.5 , pp. 468-477
    • Shinmei, S.1    Sakamoto, N.2    Goto, K.3
  • 50
    • 77950300363 scopus 로고    scopus 로고
    • Identification of a microRNA panel for clear-cell kidney cancer
    • Juan D, Alexe G, Antes T et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 75(4), 835-841 (2010).
    • (2010) Urology , vol.75 , Issue.4 , pp. 835-841
    • Juan, D.1    Alexe, G.2    Antes, T.3
  • 51
    • 84862026516 scopus 로고    scopus 로고
    • Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma
    • Valera VA, Walter BA, Linehan WM, Merino MJ. Regulatory effects of microRNA-92 (miR-92) on VHL gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma. J. Cancer 2, 515-526 (2011).
    • (2011) J. Cancer , vol.2 , pp. 515-526
    • Valera, V.A.1    Walter, B.A.2    Linehan, W.M.3    Merino, M.J.4
  • 52
    • 77953483108 scopus 로고    scopus 로고
    • MicroRNA-210: A unique and pleiotropic hypoxamir
    • Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9(6), 1072-1083 (2010).
    • (2010) Cell Cycle , vol.9 , Issue.6 , pp. 1072-1083
    • Chan, S.Y.1    Loscalzo, J.2
  • 53
    • 84870929798 scopus 로고    scopus 로고
    • Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
    • Zhao A, Li G, Peoc'h M, Genin C, Gigante M. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp. Mol. Pathol. 94(1), 115-120 (2013).
    • (2013) Exp. Mol. Pathol. , vol.94 , Issue.1 , pp. 115-120
    • Zhao, A.1    Li, G.2    Peoc'H, M.3    Genin, C.4    Gigante, M.5
  • 54
    • 84861940940 scopus 로고    scopus 로고
    • High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
    • Zhang C, Zhang J, Hao J et al. High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J. Transl. Med. 10(1), 119 (2012).
    • (2012) J. Transl. Med. , vol.10 , Issue.1 , pp. 119
    • Zhang, C.1    Zhang, J.2    Hao, J.3
  • 55
    • 70949104622 scopus 로고    scopus 로고
    • MiR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation
    • Garofalo M, Di Leva G, Romano G et al. miR-221 and 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16(6), 498-509 (2009).
    • (2009) Cancer Cell , vol.16 , Issue.6 , pp. 498-509
    • Garofalo, M.1    Di Leva, G.2    Romano, G.3
  • 56
    • 80053576554 scopus 로고    scopus 로고
    • MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer
    • Shah M, Calin G. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 3(8), 56 (2011).
    • (2011) Genome Med. , vol.3 , Issue.8 , pp. 56
    • Shah, M.1    Calin, G.2
  • 57
    • 84876072586 scopus 로고    scopus 로고
    • EGFR signaling pathway and related-miRNAs in age-related diseases: The example of miR-221 and miR-222
    • Teixeira AL, Gomes M, Medeiros R. EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222. Front. Genet. 3(286), 7 (2012).
    • (2012) Front. Genet. , vol.3 , Issue.286 , pp. 7
    • Teixeira, A.L.1    Gomes, M.2    Medeiros, R.3
  • 58
    • 80053586899 scopus 로고    scopus 로고
    • MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels
    • Wulfken LM, Moritz R, Ohlmann C et al. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS ONE 6(9), e25787 (2011).
    • (2011) PLoS ONE , vol.6 , Issue.9
    • Wulfken, L.M.1    Moritz, R.2    Ohlmann, C.3
  • 59
    • 0033954247 scopus 로고    scopus 로고
    • Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha
    • Ravi R, Mookerjee B, Bhujwalla ZM et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14(1), 34-44 (2000).
    • (2000) Genes Dev. , vol.14 , Issue.1 , pp. 34-44
    • Ravi, R.1    Mookerjee, B.2    Bhujwalla, Z.M.3
  • 60
    • 77956294987 scopus 로고    scopus 로고
    • Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents
    • Lou JJ, Chua YL, Chew EH, Gao J, Bushell M, Hagen T. Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents. PLoS ONE 5(5), e10522 (2010).
    • (2010) PLoS ONE , vol.5 , Issue.5
    • Lou, J.J.1    Chua, Y.L.2    Chew, E.H.3    Gao, J.4    Bushell, M.5    Hagen, T.6
  • 61
    • 84858712300 scopus 로고    scopus 로고
    • Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
    • Redova M, Poprach A, Nekvindova J et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J. Transl. Med. 10, 55 (2012).
    • (2012) J. Transl. Med. , vol.10 , pp. 55
    • Redova, M.1    Poprach, A.2    Nekvindova, J.3
  • 62
    • 84897102977 scopus 로고    scopus 로고
    • Circulating microRNA-222 in plasma -A potencial biomarker for renal cell carcinoma
    • Teixeira AL, Silva J, Ferreira M et al. Circulating microRNA-222 in plasma -a potencial biomarker for renal cell carcinoma. Eur. J. Cancer 48(Suppl. 5), S216 (2012).
    • (2012) Eur. J. Cancer , vol.48 , Issue.5 SUPPL.
    • Teixeira, A.L.1    Silva, J.2    Ferreira, M.3
  • 63
    • 84880273186 scopus 로고    scopus 로고
    • Potential biofluid markers and treatment targets for renal cell carcinoma
    • Wettersten HI, Weiss RH. Potential biofluid markers and treatment targets for renal cell carcinoma. Nat. Rev. Urol. 10(6), 336-344 (2013).
    • (2013) Nat. Rev. Urol. , vol.10 , Issue.6 , pp. 336-344
    • Wettersten, H.I.1    Weiss, R.H.2
  • 64
    • 70350755290 scopus 로고    scopus 로고
    • MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
    • Jung M, Mollenkopf HJ, Grimm C et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J. Cell. Mol. Med. 13(9B), 3918-3928 (2009).
    • (2009) J. Cell. Mol. Med. , vol.13 , Issue.9 B , pp. 3918-3928
    • Jung, M.1    Mollenkopf, H.J.2    Grimm, C.3
  • 65
    • 79957773360 scopus 로고    scopus 로고
    • Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
    • Koturbash I, Zemp FJ, Pogribny I, Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutat. Res. 722(2), 94-105 (2011).
    • (2011) Mutat. Res. , vol.722 , Issue.2 , pp. 94-105
    • Koturbash, I.1    Zemp, F.J.2    Pogribny, I.3    Kovalchuk, O.4
  • 66
    • 79953234117 scopus 로고    scopus 로고
    • Accurate molecular classification of kidney cancer subtypes using microRNA signature
    • Youssef YM, White NM, Grigull J et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. Eur. Urol. 59(5), 721-730 (2011).
    • (2011) Eur. Urol. , vol.59 , Issue.5 , pp. 721-730
    • Youssef, Y.M.1    White, N.M.2    Grigull, J.3
  • 67
    • 79651469908 scopus 로고    scopus 로고
    • Role of miR-10b in breast cancer metastasis
    • Ma L. Role of miR-10b in breast cancer metastasis. Breast Cancer Res. 12(5), 26 (2010).
    • (2010) Breast Cancer Res. , vol.12 , Issue.5 , pp. 26
    • Ma, L.1
  • 68
    • 84255192032 scopus 로고    scopus 로고
    • MiR-221 silencing blocks hepatocellular carcinoma and promotes survival
    • Park JK, Kogure T, Nuovo GJ et al. miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 71(24), 7608-7616 (2011).
    • (2011) Cancer Res. , vol.71 , Issue.24 , pp. 7608-7616
    • Park, J.K.1    Kogure, T.2    Nuovo, G.J.3
  • 69
    • 66449136951 scopus 로고    scopus 로고
    • Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
    • Kota J, Chivukula RR, O'Donnell KA et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137(6), 1005-1017 (2009).
    • (2009) Cell , vol.137 , Issue.6 , pp. 1005-1017
    • Kota, J.1    Chivukula, R.R.2    O'Donnell, K.A.3
  • 70
    • 84885472168 scopus 로고    scopus 로고
    • Accessed 1 March 2013
    • GeneCards®. www.genecards.org (Accessed 1 March 2013)
    • GeneCards®.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.